On Tuesday, Sage Therapeutics Inc (NASDAQ: SAGE) opened higher 3.56% from the last session, before settling in for the closing price of $7.86. Price fluctuations for SAGE have ranged from $7.70 to $28.26 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 3395.58% over the last five years. Company’s average yearly earnings per share was noted 28.28% at the time writing. With a float of $50.12 million, this company’s outstanding shares have now reached $60.04 million.
The firm has a total of 487 workers. Let’s measure their productivity.
Sage Therapeutics Inc (SAGE) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Sage Therapeutics Inc is 17.90%, while institutional ownership is 90.41%.
Sage Therapeutics Inc (SAGE) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 28.28% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 16.80% during the next five years compared to -2.28% drop over the previous five years of trading.
Sage Therapeutics Inc (NASDAQ: SAGE) Trading Performance Indicators
Check out the current performance indicators for Sage Therapeutics Inc (SAGE). In the past quarter, the stock posted a quick ratio of 9.95. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 5.11.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -7.41, a number that is poised to hit -1.56 in the next quarter and is forecasted to reach -4.99 in one year’s time.
Technical Analysis of Sage Therapeutics Inc (SAGE)
Analysing the last 5-days average volume posted by the [Sage Therapeutics Inc, SAGE], we can find that recorded value of 0.61 million was lower than the volume posted last year of 1.09 million. As of the previous 9 days, the stock’s Stochastic %D was 6.54%. Additionally, its Average True Range was 0.69.
During the past 100 days, Sage Therapeutics Inc’s (SAGE) raw stochastic average was set at 3.49%, which indicates a significant decrease from 11.78% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 63.01% in the past 14 days, which was lower than the 75.06% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $10.74, while its 200-day Moving Average is $17.21. Now, the first resistance to watch is $8.33. This is followed by the second major resistance level at $8.52. The third major resistance level sits at $8.79. If the price goes on to break the first support level at $7.87, it is likely to go to the next support level at $7.60. Now, if the price goes above the second support level, the third support stands at $7.41.
Sage Therapeutics Inc (NASDAQ: SAGE) Key Stats
There are currently 60,182K shares outstanding in the company with a market cap of 496.95 million. Presently, the company’s annual sales total 86,460 K according to its annual income of -541,490 K. Last quarter, the company’s sales amounted to 8,650 K and its income totaled -102,850 K.
